» Articles » PMID: 37443708

P38γ MAPK Inflammatory and Metabolic Signaling in Physiology and Disease

Overview
Journal Cells
Publisher MDPI
Date 2023 Jul 14
PMID 37443708
Authors
Affiliations
Soon will be listed here.
Abstract

p38γ MAPK (also called ERK6 or SAPK3) is a family member of stress-activated MAPKs and has common and specific roles as compared to other p38 proteins in signal transduction. Recent studies showed that, in addition to inflammation, p38γ metabolic signaling is involved in physiological exercise and in pathogenesis of cancer, diabetes, and Alzheimer's disease, indicating its potential as a therapeutic target. p38γphosphorylates at least 19 substrates through which p38γ activity is further modified to regulate life-important cellular processes such as proliferation, differentiation, cell death, and transformation, thereby impacting biological outcomes of p38γ-driven pathogenesis. P38γ signaling is characterized by its unique reciprocal regulation with its specific phosphatase PTPH1 and by its direct binding to promoter DNAs, leading to transcriptional activation of targets including cancer-like stem cell drivers. This paper will review recent findings about p38γ inflammation and metabolic signaling in physiology and diseases. Moreover, we will discuss the progress in the development of p38γ-specific pharmacological inhibitors for therapeutic intervention in disease prevention and treatment by targeting the p38γ signaling network.

Citing Articles

Network Pharmacology and Machine Learning Reveal Salidroside's Mechanisms in Idiopathic Pulmonary Fibrosis Treatment.

Ding C, Guo Z, Liao Q, Zuo R, He J, Ye Z J Inflamm Res. 2024; 17:9453-9467.

PMID: 39600682 PMC: 11590657. DOI: 10.2147/JIR.S493171.


SPARC activates p38γ signaling to promote PFKFB3 protein stabilization and contributes to keloid fibroblast glycolysis.

Liu Y, Zhang W, Lin N, Yang Z, Liu Y, Chen H Inflamm Regen. 2024; 44(1):44.

PMID: 39482755 PMC: 11529245. DOI: 10.1186/s41232-024-00357-y.


Collagen II enrichment through scAAV6-RNAi-mediated inhibition of matrix-metalloproteinases 3 and 13 in degenerative nucleus-pulposus cells degenerative disc disease and biological treatment strategies.

Mern D, Thome C Exp Biol Med (Maywood). 2024; 249:10048.

PMID: 39286594 PMC: 11402661. DOI: 10.3389/ebm.2024.10048.


SDS3 regulates microglial inflammation by modulating the expression of the upstream kinase ASK1 in the p38 MAPK signaling pathway.

Shen J, Lai W, Li Z, Zhu W, Bai X, Yang Z Inflamm Res. 2024; 73(9):1547-1564.

PMID: 39008037 PMC: 11349808. DOI: 10.1007/s00011-024-01913-5.


Pirfenidone ameliorates alcohol-induced promotion of breast cancer in mice.

Li H, Xu M, Chen D, Wen W, Luo J Front Oncol. 2024; 14:1351839.

PMID: 38590657 PMC: 10999600. DOI: 10.3389/fonc.2024.1351839.


References
1.
Qi X, Tang J, Loesch M, Pohl N, Alkan S, Chen G . p38gamma mitogen-activated protein kinase integrates signaling crosstalk between Ras and estrogen receptor to increase breast cancer invasion. Cancer Res. 2006; 66(15):7540-7. PMC: 2174269. DOI: 10.1158/0008-5472.CAN-05-4639. View

2.
King Jr T, Bradford W, Castro-Bernardini S, Fagan E, Glaspole I, Glassberg M . A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014; 370(22):2083-92. DOI: 10.1056/NEJMoa1402582. View

3.
Hasegawa M, Cuenda A, Spillantini M, Thomas G, Cohen P, Goedert M . Stress-activated protein kinase-3 interacts with the PDZ domain of alpha1-syntrophin. A mechanism for specific substrate recognition. J Biol Chem. 1999; 274(18):12626-31. DOI: 10.1074/jbc.274.18.12626. View

4.
Loesch M, Chen G . The p38 MAPK stress pathway as a tumor suppressor or more?. Front Biosci. 2008; 13:3581-93. PMC: 4758212. DOI: 10.2741/2951. View

5.
Canovas B, Nebreda A . Diversity and versatility of p38 kinase signalling in health and disease. Nat Rev Mol Cell Biol. 2021; 22(5):346-366. PMC: 7838852. DOI: 10.1038/s41580-020-00322-w. View